Otsuka Holdings
4578.T
#642
Rank
โ‚น3.605 T
Marketcap
โ‚น6,881
Share price
-6.76%
Change (1 day)
40.49%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

Earnings for Otsuka Holdings (4578.T)

Earnings in 2026 (TTM): โ‚น303.12 Billion

According to Otsuka Holdings 's latest financial reports the company's current earnings are โ‚น16.95 Billion. In 2025 the company made an earning of โ‚น312.68 Billion, an increase over its 2024 earnings that were of โ‚น214.51 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Otsuka Holdings from 2010 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น303.12 B-3.06%
2025 โ‚น312.68 B45.77%
2024 โ‚น214.51 B117.32%
2023 โ‚น98.70 B-20.93%
2022 โ‚น124.83 B-12.7%
2021 โ‚น142.99 B-19.92%
2020 โ‚น178.57 B13.9%
2019 โ‚น156.78 B52.07%
2018 โ‚น103.10 B11.22%
2017 โ‚น92.69 B-36.03%
2016 โ‚น144.90 B31.15%
2015 โ‚น110.48 B
2013 โ‚น229.33 B33.52%
2012 โ‚น171.75 B-4.65%
2011 โ‚น180.13 B45.53%
2010 โ‚น123.78 B